Pitfalls of commercially available HPV tests in HPV68a detection.

Hana JaworekKaterina Kubanova Vladimira KoudelakovaRastislav SlavkovskyJiří DrábekMarian Hajduch

Published in: PloS one (2019)

The HPV68a subtype was missed by cobas 4800 in more than 85% of all HPV68a-positive cases. Therefore, commercially available assays may underestimate HPV68 prevalence.

Keyphrases

high grade
cervical cancer screening
risk factors
quantum dots
label free